Charming Medical Limited (MCTA) Fair Value 2026

MCTA · Medical Care Facilities ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.1 /10

32 fundamental signals · 5 models active

Value Trap Risk

SAFE (0/100)

Quick Summary — As of 2026-08-31, Charming Medical Limited (MCTA) trades at $29.36, versus a $0.62 median fair value across its 5 active models — 97.9% below the current price. QOC: 6.1/10. Value Trap Risk: 0/100 (SAFE). 5/13 models active.

Key Facts

Ticker
MCTA
Price
$29.36
Quality Score
6.1/10
Value Trap Risk
0/100
Models Active
5/13
Last Updated
Strength: 5 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is Charming Medical Limited (MCTA) Undervalued or Overvalued in 2026?

According to CirclFi’s 5-model valuation engine, Charming Medical Limited (MCTA) appears overvalued as of : the median of 5 independent fair value estimates is $0.62, 97.9% below the current price of $29.36. Estimates range from $0.36 to $0.69. MCTA scores 6.1/10 on fundamental quality and 0/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.1% versus its own 13-model consensus, across 3,804 rated companies as of 2026-08-31. MCTA’s -97.9% gap is wider than that market norm, and the Medical Care Facilities sector median is -27.9%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Charming Medical Limited Stock in 2026? →

What Fair Value Does Each Model Give MCTA?

5 Intrinsic Value Models vs. Current Price ($29.36)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $0.69 -97.7%
Ensemble · Low Conviction
 $0.62 -97.9%
Unlock the Full Matrix

Access 3 additional models including Regime Cross-Sectional, Sentiment SOTP, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 5 Models →

Cancel anytime · No contracts · Instant access

What Is MCTA's Fair Value Range?

Spread across 5 independent models · $0.36 to $0.69

CirclFi's 5 active models place Charming Medical Limited (MCTA) between $0.36 and $0.69 per share, a spread of 53% of the median. The median of that range — $0.62 — is the fair value CirclFi publishes for MCTA, against a current price of $29.36.

Low · Regime CrossHigh · EPV
$0.36median $0.62$0.69
Where the range comes from
Most bearish modelRegime Cross-Sectional$0.36
Most bullish modelEarnings Power Value (EPV)$0.69
Model agreement0 bullish · 5 bearishmoderate

A band of this width is typical. The methods agree on direction but weight growth, reinvestment and risk differently, so treat the median as a centre of gravity rather than a precise target.

Every figure above is one model's standalone output on MCTA, not a CirclFi price target. How each model works →

What Is Charming Medical Limited (MCTA) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Charming Medical Limited's intrinsic value is estimated at $0.62, suggesting the stock is overvalued at its current price of $29.36. With 5 out of 5 models flagging downside (-97.9% vs price), the market may be pricing in unsustainable growth.

What Do the Models Say About MCTA?

5 of 13 models are currently active for MCTA. All 5 active models suggest the stock trades above fair value. Taken together, their median fair value for MCTA is $0.62 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does MCTA Rank in Medical Care Facilities?

Among 60 Medical Care Facilities stocks, MCTA ranks #36 by Quality of Company score. CirclFi's QOC score of 6.1/10 evaluates 32 fundamental signals. A score of 6.1 indicates above-average quality.

See all Most Undervalued Medical Care Facilities Stocks →

Charming Medical Limited operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is MCTA a Value Trap?

CirclFi's Value Trap algorithm assigns MCTA a score of 0/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

5 of 13 models are active for Charming Medical Limited. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Charming Medical Limited's fundamental quality profile registers 6.1/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

Models cluster within a tight range (+1.1% spread), increasing conviction. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every MCTA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across MCTA's 5 active models, average confidence is 16%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Charming Medical Limited Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Care Facilities Stocks Should You Also Analyze?

11 related Medical Care Facilities stocks with 13-model coverage

AIRSAirSculpt Technologies, Inc.QOC 6.1CCMConcord Medical Services Holdings LimitedQOC 6.1RHEPRegional Health Properties, Inc.QOC 6.2SYRASyra Health Corp.QOC 5.9SGRYSurgery Partners, Inc.QOC 6.4AGLagilon health, inc.QOC 5.9BMGLBasel Medical Group LtdQOC 4.8OPCHOption Care Health, Inc.QOC 8.4FMSFresenius Medical Care AGQOC 7.3ADUSAddus HomeCare CorporationQOC 8.9NHCNational HealthCare CorporationQOC 8.7

Read investment analysis: AIRS · CCM · RHEP · SYRA · SGRY · AGL · BMGL · OPCH · FMS · ADUS · NHC

Which Other Stocks Have a Similar Quality Score to MCTA?

7 companies across all industries closest to MCTA’s Quality of Company score of 6.1/10.

GHIGreystone Housing Impact Investors LPQOC 6.1AMRNAmarin Corporation plcQOC 6.1IMDXInsight Molecular Diagnostics Inc.QOC 6.1IIIVi3 Verticals, Inc.QOC 6.1TICTIC Solutions, Inc.QOC 6.1HTFLHeartflow, Inc.QOC 6.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: GHI · AMRN · IMDX · IIIV · TIC · HTFL · NVDA

Where Does MCTA Sit in CirclFi's Medical Care Facilities Rankings?

MCTA is ranked against every other Medical Care Facilities stock CirclFi covers in each of these screens.

See all Medical Care Facilities stocks ranked →

What Else Do Investors Ask About Charming Medical Limited’s Valuation?

What is Charming Medical Limited's intrinsic value in 2026?

CirclFi puts Charming Medical Limited (MCTA)'s intrinsic value at $0.62 — the median of 5 independent model estimates as of 2026-08-31, ranging from $0.36 to $0.69. The Quality of Company score is 6.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is MCTA overvalued or undervalued right now?

At $29.36, 0 of 5 active models suggest MCTA may be undervalued, while 5 indicate potential overvaluation. The median of all 5 fair value estimates is $0.62, 97.9% below the current price of $29.36 — a consensus view that MCTA is overvalued. The assessment depends on which methodology best fits Charming Medical Limited's business model in Medical Care Facilities.

What does a Quality of Company score of 6.1 mean for MCTA?

Charming Medical Limited's QOC of 6.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on MCTA?

CirclFi analyzes MCTA with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 5 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on MCTA?

Of the 5 models currently active on MCTA, Earnings Power Value (EPV) is the most bullish at $0.69 per share, and Regime Cross-Sectional is the most bearish at $0.36. CirclFi's published fair value for MCTA is the median of that range, $0.62, not either extreme. The gap between the two ends equals 53% of the median — a normal spread for a company of this profile. Browse stocks by value-trap risk →

Is MCTA a value trap in 2026?

Charming Medical Limited's Value Trap score is 0/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 5-model valuation engine, Charming Medical Limited (MCTA) has a median fair value of $0.62 — 97.9% below the current price of $29.36 — as of 2026-08-31.” Source: circlfi.com/stock/MCTA/ · Methodology
Primary sources for this MCTA valuation
  • Financial statements: Charming Medical Limited 10-K and 10-Q filings on SEC EDGAR (CIK 0002035992) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for MCTA as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 5 mathematical frameworks give you clarity on MCTA.

Unlock All 5 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

3 models hidden for MCTA Unlock All 5 — $39/mo